asthma
chronic
inflammatori
airway
diseas
suscept
trigger
factor
aeroallergen
air
pollut
viral
infect
despit
major
advanc
prevent
manag
asthma
remain
consider
global
healthcar
burden
crude
preval
asthma
increas
current
million
case
asthma
global
despit
dramat
reduct
agestandard
mortal
million
peopl
die
asthma
manag
asthma
exacerb
consist
link
upper
andor
lower
airway
infect
import
health
issu
among
schoolag
children
viral
infect
reportedli
account
asthma
exacerb
virus
frequent
isol
symptomat
patient
asymptomat
patient
although
rhinoviru
rv
frequent
detect
asthmat
patient
asthma
exacerb
also
associ
infect
respiratori
virus
includ
adenoviru
adv
bocaviru
bov
coronaviru
cov
cytomegaloviru
cmv
enteroviru
env
herp
simplex
viru
hsv
influenza
viru
ifv
metapneumoviru
mpv
parainfluenzaviru
piv
respiratori
syncyti
viru
rsv
unfortun
rate
associ
virus
asthma
exacerb
remain
controversi
hypothet
explan
might
substanti
differ
studi
design
popul
geograph
region
detect
method
type
respiratori
tract
secret
examin
despit
increas
understand
role
virus
play
asthma
exacerb
less
clear
virus
involv
extent
contribut
asthma
exacerb
differ
subgroup
subject
conduct
systemat
review
preval
viral
infect
patient
asthma
exacerb
subgroup
analys
identifi
determin
variat
find
may
offer
better
overview
develop
prevent
intervent
minim
virusinduc
asthma
exacerb
studi
search
comprehens
embas
pubm
cochran
central
regist
control
trial
ebm
reviewscochran
databas
systemat
review
web
scienc
ovid
highwir
june
dateofstart
specifi
refer
check
addit
data
restrict
search
list
public
english
languag
popul
use
analysi
sever
public
largest
complet
studi
includ
adopt
combin
keyword
relat
viru
detect
adenoviru
bocaviru
metapneumoviru
coronaviru
epsteinbarr
viru
influenza
viru
parainfluenza
viru
rhinoviru
enteroviru
respiratori
syncyti
viru
outcom
asthma
exacerb
pulmonari
diseas
chronic
obstruct
mesh
diseas
progress
mesh
copd
exacerb
virus
mesh
respiratori
viral
infect
respiratori
viru
polymeras
chain
reaction
mesh
viru
pcr
crosssect
prospect
studi
cohort
studi
casecontrol
studi
detail
preval
respiratori
viru
es
asthma
exacerb
includ
elig
asthmat
patient
diagnos
viral
infect
base
polymeras
chain
reaction
pcr
enzymelink
immunosorb
assay
elisa
cell
culturedirect
fluoresc
antibodi
assay
dfa
indirect
fluoresc
antibodi
assay
ifa
evalu
exacerb
studi
investig
asthma
exacerb
children
adult
exclud
anim
studi
ex
vivo
toxicolog
studi
summari
commentari
editori
case
report
case
seri
duplic
public
samplerel
laboratorybas
studi
studi
intens
care
set
patient
concomit
chronic
obstruct
pulmonari
diseas
bronchiectasi
immunosuppress
nonpeer
review
articl
potenti
sourc
bia
nonorigin
data
nosocomi
infect
hospit
within
four
week
delay
sampl
collect
h
hospit
author
contact
via
email
data
incomplet
studi
exclud
repli
obtain
despit
repeat
contact
correspond
author
studi
compli
prefer
report
item
metaanalysi
qualiti
individu
studi
assess
base
revis
qualiti
assess
diagnost
accuraci
tool
highest
total
score
higher
score
indic
lower
risk
bia
two
independ
review
xyz
yjx
screen
abstract
titl
full
text
review
determin
elig
disagr
resolv
discuss
consensu
reach
anoth
review
wjg
consult
vote
final
decis
standard
form
use
data
extract
includ
main
characterist
author
year
public
sampl
size
age
definit
exacerb
qualiti
detect
method
studi
design
season
primari
outcom
preval
viral
infect
asthma
exacerb
secondari
outcom
preval
virus
differ
strata
data
extract
done
two
independ
review
xyz
lfl
disagr
resolv
consult
third
review
wjg
metaanalysi
obtain
point
estim
rate
asthma
exacerb
associ
viral
infect
across
whole
age
spectrum
global
dersimonian
laird
randomeffect
model
appli
heterogen
among
studi
greater
varianc
raw
proport
report
studi
stabil
use
untransform
proport
logarithm
transform
logit
transform
arcsin
transform
freemantukeytyp
arcsin
squareroot
transform
accord
shapirowilk
test
normal
data
distribut
also
subgroup
analysi
assess
weight
viral
infect
asthma
exacerb
respect
geograph
region
popul
type
respiratori
tract
secret
examin
detect
method
one
studi
avail
calcul
confid
interv
ci
use
clopperpearson
exact
test
differ
geograph
region
age
studi
popul
type
respiratori
tract
secret
detect
method
significantli
confound
determin
preval
individu
virus
heterogen
assess
studi
analys
conduct
r
softwar
version
articl
relev
object
exclud
addit
studi
identifi
citat
within
articl
figur
summar
select
process
sixti
articl
studi
analyz
assess
associ
viru
infect
asthma
exacerb
characterist
patient
popul
studi
design
countri
sampl
size
asthma
definit
qualiti
score
detect
method
studi
design
type
respiratori
tract
secret
examin
virus
involv
vari
substanti
etabl
elig
studi
cross
section
studi
casecontrol
studi
cohort
studi
seven
prospect
studi
studi
conduct
durat
vari
one
month
year
asthma
diagnos
physician
studi
data
report
burden
asthma
mean
age
asthmat
patient
vari
among
differ
studi
therefor
children
adult
dichotom
report
upperlow
airway
specimen
screen
differ
method
includ
pcr
dfa
assay
ifa
assay
viru
cultur
elisa
rapid
enzym
immunoassay
viru
neutral
test
criteria
qualiti
assess
risk
bia
individu
studi
summar
etabl
mean
score
qualiti
assess
rang
includ
studi
least
partial
prone
report
bia
overal
mean
preval
ci
rv
highest
follow
rsv
hsv
env
ifv
cov
cmv
bov
piv
mpv
adv
tabl
fig
data
stratifi
age
top
five
estim
preval
children
rv
rsv
env
cov
ifv
howev
adult
rv
cov
piv
bov
ifv
frequent
isol
case
asthma
exacerb
tabl
fig
stratifi
geograph
region
five
major
virus
associ
asthma
exacerb
europ
rv
rsv
bov
env
cov
asia
order
preval
five
major
virus
rv
follow
env
ifv
piv
rsv
rank
america
rv
follow
cov
ifv
rsv
mpv
rv
frequent
isol
viru
asthma
exacerb
oceania
follow
bov
env
piv
mpv
howev
africa
asthma
exacerb
mainli
attribut
rsv
mpv
piv
adv
ifv
tabl
fig
stratif
base
type
respiratori
tract
secret
analyz
show
upper
airway
secret
top
five
preval
virus
rv
rsv
ifv
env
bov
howev
analyz
lower
airway
secret
asthma
exacerb
attribut
frequent
rv
follow
ifv
adv
piv
rsv
tabl
fig
bov
env
frequent
detect
oronasopharyng
aspir
wherea
adv
primarili
detect
induc
sputum
cov
ifv
mpv
piv
frequent
detect
oronasopharyng
lavag
rv
rsv
virus
frequent
detect
spontan
oronasopharyng
secret
tabl
overal
pcr
sensit
techniqu
detect
adv
bov
env
ifv
mpv
piv
respiratori
virus
compar
ifa
elisa
dfa
viru
cultur
elisa
yield
highest
detect
rate
cov
rsv
tabl
fig
studi
gather
latest
data
preval
virus
detect
asthma
exacerb
asthma
exacerb
mainli
associ
rv
highlight
prioriti
intervent
reduc
substanti
healthcar
burden
caus
virus
find
echo
high
preval
rv
among
unselect
popul
resid
north
america
netherland
rv
preval
among
symptomat
children
wheez
episod
convalesc
well
healthi
children
possibl
explan
rv
common
resid
pathogen
prone
caus
upper
airway
infect
eg
common
cold
consist
rv
isol
pharyng
exud
sampl
mexican
acut
upper
respiratori
tract
infect
preval
virus
vari
consider
among
differ
studi
exampl
rang
rsv
env
detail
see
onlin
supplement
intriguingli
mean
estim
preval
env
hsv
ifv
rsv
greater
wherea
individu
respiratori
viru
mean
preval
less
patient
respiratori
diseas
preval
virus
partial
mirror
find
rsv
reportedli
found
elderli
patient
acut
respiratori
ill
mexican
acut
upper
respiratori
tract
infect
env
isol
young
infant
sepsislik
ill
bov
detect
nasopharyng
aspir
hospit
children
spain
howev
preval
mpv
higher
mexican
acut
upper
respiratori
tract
infect
preval
adv
also
higher
among
hospit
children
spain
pool
analysi
substanti
heterogen
preval
data
probabl
due
differ
studi
design
ethnic
geograph
region
site
sampl
collect
detect
method
therefor
direct
comparison
remain
challeng
therefor
subgroup
analysi
done
identifi
possibl
determin
variat
next
stratifi
preval
data
age
env
mpv
rv
rsv
preval
children
wherea
adv
bov
cov
ifv
piv
preval
adult
env
mpv
associ
asthma
exacerb
children
rv
frequent
associ
asthma
exacerb
associ
upper
respiratori
tract
infect
children
rsv
commonli
link
onset
wheez
childhood
signific
variat
virus
involv
probabl
reflect
major
shift
develop
hostdefens
mechan
associ
specif
virus
vari
consider
across
geograph
region
rv
common
viru
asia
europ
america
oceania
rv
probabl
domin
resid
viru
colon
upper
lower
airway
onlin
supplement
irrespect
meteorolog
factor
temperatur
humid
rsv
report
common
among
popul
africa
could
partial
relat
gener
higher
preval
lowincom
countri
howev
reason
variat
preval
common
respiratori
virus
known
research
warrant
determin
whether
ethnicityrel
suscept
meteorolog
factor
play
signific
role
shape
preval
viral
infect
consist
literatur
report
onlin
supplement
text
rv
detect
upper
lower
airway
rsv
apart
greater
likelihood
initi
infect
nasopharyng
mucosa
follow
spread
viru
lower
airway
extens
use
nasal
swab
spontan
induc
sputum
sampl
collect
children
might
also
result
higher
appar
preval
upper
airway
secret
furthermor
higher
preval
bov
env
detect
upper
airway
secret
might
associ
fecaltoor
transmiss
transmiss
oral
mucosa
salivari
gland
would
detect
frequent
infant
toddler
accord
literatur
report
pcr
sensit
method
detect
virus
asthma
exacerb
simpl
rapid
costeffect
techniqu
becom
mainstay
viral
detect
whilst
viru
isol
cell
cultur
remain
gold
standard
timeconsum
laborintens
render
unsuit
rapid
batch
detect
clinic
set
due
limit
sensit
specif
techniqu
dfa
ifa
less
frequent
appli
clinic
find
confirm
virus
variou
speci
close
associ
asthma
exacerb
mechan
multifacet
includ
necrosi
airway
epithelium
ciliostasi
loss
cilia
excess
releas
proinflammatori
cytokin
chemokin
airway
hyperrespons
remodel
due
epitheli
injuri
mucu
hypersecret
imped
mucociliari
clearanc
unfortun
effect
treatment
option
eg
immunoglobin
nebul
antivir
direct
elimin
viral
infect
preemptiv
approach
direct
prevent
viral
infect
particularli
suscept
popul
eg
children
pregnant
women
elderli
patient
comorbid
exemplifi
vaccin
develop
prevent
rsv
influenza
viru
infect
prioriti
given
common
virus
eg
rv
rsv
hsv
env
ifv
caus
signific
healthcar
burden
recent
polyval
vaccin
rv
develop
anim
model
indic
possibl
establish
herd
immun
use
polyval
multipleviru
vaccin
futur
communitybas
practic
might
help
achiev
greater
reduct
preval
virusinduc
asthma
exacerb
result
may
readili
extrapol
countri
instanc
document
preval
multipl
virus
africa
still
lack
littl
known
regard
distribut
specif
viral
strain
due
small
number
studi
relev
subgroup
analys
eg
cell
cultur
dfa
assay
even
slight
variat
individu
studi
might
signific
effect
modifi
global
estim
summar
preval
respiratori
virus
associ
asthma
exacerb
rv
env
rsv
preval
therefor
preemptiv
prophylaxi
effect
vaccin
novel
antivir
agent
need
minim
healthcar
burden
asthma
exacerb
result
viral
infect
